141 related articles for article (PubMed ID: 26365986)
1. MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma.
Zheng X; Li J; Peng C; Zhao J; Chi J; Meng X; Yun X; Li D; Yu Y; Gao M; Li Y
Oral Oncol; 2015 Nov; 51(11):998-1003. PubMed ID: 26365986
[TBL] [Abstract][Full Text] [Related]
2. miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1.
Jia LF; Huang YP; Zheng YF; Lyu MY; Wei SB; Meng Z; Gan YH
Oral Oncol; 2014 Nov; 50(11):1062-71. PubMed ID: 25127200
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
Yang H; Kong W; He L; Zhao JJ; O'Donnell JD; Wang J; Wenham RM; Coppola D; Kruk PA; Nicosia SV; Cheng JQ
Cancer Res; 2008 Jan; 68(2):425-33. PubMed ID: 18199536
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
6. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
[TBL] [Abstract][Full Text] [Related]
7. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
Jia LF; Gan YH; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
9. YY1-mediated PTEN dephosphorylation antagonizes IR-induced DNA repair contributing to tongue squamous cell carcinoma radiosensitization.
Zhao L; Li R; Qiu JZ; Yu JB; Cao Y; Yuan RT
Mol Cell Probes; 2020 Oct; 53():101577. PubMed ID: 32334006
[TBL] [Abstract][Full Text] [Related]
10. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
[TBL] [Abstract][Full Text] [Related]
11. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
12. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1.
Fan S; Chen WX; Lv XB; Tang QL; Sun LJ; Liu BD; Zhong JL; Lin ZY; Wang YY; Li QX; Yu X; Zhang HQ; Li YL; Wen B; Zhang Z; Chen WL; Li JS
Cancer Lett; 2015 Jul; 362(2):183-91. PubMed ID: 25843291
[TBL] [Abstract][Full Text] [Related]
13. Loss of PTEN Expression Is Associated With High MicroRNA 24 Level and Poor Prognosis in Patients With Tongue Squamous Cell Carcinoma.
Zhao J; Chi J; Gao M; Zhi J; Li Y; Zheng X
J Oral Maxillofac Surg; 2017 Jul; 75(7):1449.e1-1449.e8. PubMed ID: 28413152
[TBL] [Abstract][Full Text] [Related]
14. miR-203 inhibits cell proliferation and promotes cisplatin induced cell death in tongue squamous cancer.
Lin J; Lin Y; Fan L; Kuang W; Zheng L; Wu J; Shang P; Wang Q; Tan J
Biochem Biophys Res Commun; 2016 Apr; 473(2):382-7. PubMed ID: 26946357
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4.
Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K
Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.
Wu X; Gong Z; Sun L; Ma L; Wang Q
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28319306
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.
Fan S; Liu B; Sun L; Lv XB; Lin Z; Chen W; Chen W; Tang Q; Wang Y; Su Y; Jin S; Zhang D; Zhong J; Li Y; Wen B; Zhang Z; Yang P; Zhou B; Liang Q; Yu X; Zhu Y; Hu P; Chu J; Huang W; Feng Y; Peng H; Huang Q; Song E; Li J
Oncotarget; 2015 Jun; 6(17):14885-904. PubMed ID: 25912308
[TBL] [Abstract][Full Text] [Related]
19. Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
Berania I; Cardin GB; Clément I; Guertin L; Ayad T; Bissada E; Nguyen-Tan PF; Filion E; Guilmette J; Gologan O; Soulieres D; Rodier F; Wong P; Christopoulos A
Int J Cancer; 2017 Dec; 141(11):2318-2328. PubMed ID: 28779483
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of PTEN protein in tongue squamous cell carcinoma].
Wang QX; Wang DL; Sun CF; Wang TX
Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):133-5. PubMed ID: 16685350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
